Squarepoint’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,842
Closed -$13K 2600
2018
Q4
$13K Sell
1,842
-792
-30% -$8.82K ﹤0.01% 1882
2018
Q3
$50K Buy
2,634
+595
+29% +$21.2K ﹤0.01% 1921
2018
Q2
$115K Sell
2,039
-2,829
-58% -$143K ﹤0.01% 1632
2018
Q1
$206K Buy
+4,868
New +$209K ﹤0.01% 1480
2017
Q4
Sell
-1,063
Closed -$47K 2467
2017
Q3
$47K Buy
+1,063
New +$48.4K ﹤0.01% 1565
2017
Q1
Sell
-6,925
Closed -$396K 2116
2016
Q4
$396K Buy
+6,925
New +$634K 0.02% 958
2016
Q1
Sell
-1,000
Closed -$99K 1589
2015
Q4
$99K Buy
+1,000
New +$107K 0.01% 1133

Other funds holding ELGX

Squarepoint's ELGX Position: Q1 2019 in Review

Squarepoint sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 1,842 shares — an estimated $13K sold.

Squarepoint first reported a position in ELGX in Q4 2015 and held it in 7 quarters. The position peaked at $396K in Q4 2016. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Squarepoint reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Squarepoint sold 1,842 Endologix Inc shares in Q1 2019, an estimated $13K.
  • Squarepoint first reported a position in Endologix Inc in Q4 2015 and held it in 7 quarters.
  • Squarepoint's Endologix Inc position peaked at $396K in Q4 2016.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Squarepoint's 13F filing for Q1 2019, filed 15 May 2019.